About 40% of patients with AIDS or symptomatic HIV infection will deve
lop a neurological syndrome, and 10% of all patients with AIDS will in
itially present with nervous system complaints. About half of the neur
ological manifestations are due to the effects of HIV-1 on the nervous
system and half result as opportunistic or secondary complications of
the immune deficiency induced by HIV-1. The pathogenetic mechanisms o
f the HIV-1-related neurological disorders are becoming defined and ne
w treatments directed at these mechanisms are being introduced. The pr
ognosis for the central nervous system disorders has improved with ear
lier, more precise diagnosis, and more effective treatment and prophyl
axis.